# Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN)

> **NCT00592904** · PHASE2,PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 262 (actual)

## Conditions studied

- Neuralgia

## Interventions

- **DRUG:** E2007

## Key facts

- **NCT ID:** NCT00592904
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-11
- **Final completion:** 2011-07
- **Target enrollment:** 262 (ACTUAL)
- **Last updated:** 2016-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00592904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00592904, "Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00592904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*